On January 1, 2020, Illinois became the eleventh US state to legalize recreational cannabis, and the first to do so through legislative action rather than ballot initiative. The Cannabis Regulation and Tax Act made adult-use marijuana legal for anyone 21 or older. Five years later, the state has more than 240 licensed adult-use dispensaries and a market that pulled in roughly $146.6 million in adult-use sales in April 2025 alone, on its way to total annual sales above $1.5 billion for the year.

You would expect the medical program to fade. It has not. As of April 2025, roughly 134,000 Illinois residents still held active medical cannabis cards. The number has declined modestly from a peak above 142,000 in early 2024, but the program is nowhere near collapse. The reasons patients stay are mostly economic, but they extend further than tax savings. Understanding why Illinois patients renew an Illinois MMJ card when recreational is right down the street is also a window into how dual-track cannabis markets actually function.

The 34% Tax Differential

The single biggest reason is tax. Illinois recreational cannabis carries one of the heaviest tax stacks in the United States. Adult-use buyers pay a 6.25% state sales tax, a municipal cannabis retailers’ tax of up to 3%, a county cannabis retailers’ tax of up to 3% in municipalities (3.75% in unincorporated areas), and a state cannabis purchaser excise tax that scales with THC content: 10% on products at or below 35% THC, 20% on cannabis-infused products like edibles, and 25% on concentrates and flower above 35% THC. Stacked together, a recreational consumer can pay between roughly 19.5% and 34.75% in taxes on a single purchase, depending on product type and locality.

Medical cardholders pay 1%.

For a patient managing chronic pain who buys cannabis regularly, gaining access to a cannabis card in Illinois translates directly into avoiding that tax stack and paying just 1% instead. On a $300 monthly cannabis spend, the math shifts from somewhere between $360 and $404 (recreational, depending on tax tier and locality) to roughly $303 (medical). Annualized, the savings range from approximately $700 to $1,200, several times the cost of even a three-year medical card application fee.

Possession Limits Roughly 2.4x

Volume is the second factor. Illinois recreational consumers can possess up to 30 grams (about one ounce) of cannabis flower and purchase that amount per visit. Medical patients can purchase up to 2.5 ounces (roughly 70 grams) every 14 days, more than double the recreational limit. For patients who actually use cannabis to manage daily symptoms, that difference matters. Registered home cultivators are also exempt from the 2.5-ounce possession ceiling for cannabis they have grown themselves under the program, an option not available to recreational users.

Home Cultivation Is Medical-Only

Third, home cultivation is a medical-only privilege in Illinois. The law allows medical cardholders to grow up to five mature plants at home, provided the plants are stored in a locked, enclosed space inaccessible to anyone without a card. Recreational users have no home-grow rights at all. For patients who want consistent access to specific strains, want to control product quality, or simply want to reduce dispensary spend further, the right to cultivate is a meaningful financial and lifestyle benefit.

Age Eligibility at 18

Fourth, age eligibility differs. Recreational cannabis is restricted to adults 21 and over. Illinois cardholders can be 18, with caregiver provisions extending eligibility to qualifying minors. For Illinois adults aged 18 to 20 with chronic pain, severe anxiety, PTSD, or other qualifying conditions, the medical pathway is the only legal route to access cannabis at all.

Workplace Protections

Fifth, the medical program offers employment protections that the recreational framework does not. Section 40 of the Compassionate Use of Medical Cannabis Program Act (410 ILCS 130/40) prohibits Illinois employers from refusing to hire, firing, or otherwise penalizing a person solely for their status as a registered qualifying patient. The protection has limits. Section 50 of the same Act preserves the right of employers to maintain zero-tolerance and drug-free workplace policies, and Illinois courts have generally allowed employers to discipline patients who violate those policies. Federal employees, certain safety-sensitive positions, and roles governed by Department of Transportation regulations are also excluded. Even with those carve-outs, registered patient status confers anti-discrimination protections that recreational consumers do not have at all. For workers in industries where drug testing is routine but where employers have not adopted strict zero-tolerance policies, the difference is meaningful.

Supply Priority During Shortages

Sixth, supply priority. Illinois law requires cultivators and dispensaries to reserve sufficient inventory for medical patients. During the first months of recreational legalization in 2020, several Illinois dispensaries hit stockouts as adult-use demand overwhelmed supply chains. Medical patients continued to receive their products while recreational lines were turned away. The legal framework explicitly prioritizes patients during shortages. That is structural protection a recreational consumer does not have.

Smaller Benefits That Add Up

Beyond the six primary advantages, medical cardholders also gain access to dispensaries with shorter lines (some are medical-only), product-testing standards that some patients prefer, the ability to designate a caregiver to purchase on their behalf, and legal protections in custody and family-law contexts where ongoing cannabis use must be documented as therapeutic rather than recreational. None of these are headline benefits, but for the patient population they apply to, they often tip the math.

The Structural Lesson

Illinois is now five years into its dual-track experiment, and the data tell a consistent story. Recreational legalization did not eliminate the medical market. It restructured it. The patients who remain in the medical program are mostly those who can demonstrate clear economic or clinical reasons to be there: high-volume users for whom tax savings dwarf application fees, patients with chronic conditions who need possession-limit headroom, employees who benefit from anti-discrimination protections, home cultivators, and 18-to-20-year-olds with qualifying conditions.

The pattern is showing up in other dual-track states as well. Michigan, Massachusetts, Colorado, and Nevada have all retained meaningful medical patient populations after recreational legalization. The medical program does not disappear when a state goes recreational. It becomes the program for patients who actually need the structural advantages that medical status confers.

The Calculus for Illinois Residents

For Illinois residents weighing whether the certification process is worth the trouble, the math is straightforward. If your annual cannabis spend is meaningful, if you have a qualifying condition, if you work in an industry where drug testing is routine but your employer has not adopted a strict zero-tolerance policy, or if you want to grow at home, the medical card pays for itself in the first month or two and continues paying out indefinitely. If you are a casual consumer who buys an eighth twice a year, recreational is fine.

What Illinois has built is not a replacement of medical with recreational. It is two distinct programs serving two distinct populations. Five years of data confirm that the medical program is a structural feature of the regulated market, not a transitional artifact of the pre-2020 era.

Photo: Terrance Barksdale via Pexels

CLICK HERE TO DONATE IN SUPPORT OF OUR NONPROFIT COVERAGE OF ARTS AND CULTURE